Last Updated: 21/12/2023
WHO technical consultation on preferred product characteristics for drugs used in malaria chemoprevention
Source(s):
Published: 03/11/2022
WHO technical consultation on preferred product characteristics for drugs used in malaria chemoprevention
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs to protect populations from malaria (chemoprevention), while considering relevant measures of efficacy and the safety data needed to support WHO policy recommendations.
External reference
THEMES: Drug-based Strategies
Related Resources
